FSTRX
Price
$30.51
Change
-$0.87 (-2.77%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

FSTRX vs RMFCX

Header iconFSTRX vs RMFCX Comparison
Open Charts FSTRX vs RMFCXBanner chart's image
Federated Hermes MDT Large Cap Value A
Price$30.51
Change-$0.87 (-2.77%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
FSTRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSTRX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSTRX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. FSTRX (1.33B). RMFCX pays higher dividends than FSTRX: RMFCX (1.69) vs FSTRX (1.08). FSTRX was incepted earlier than RMFCX: FSTRX (11 years) vs RMFCX (23 years). FSTRX is a more actively managed with annual turnover of: 95.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than FSTRX: RMFCX (250) vs FSTRX (1500). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. FSTRX (11.12). RMFCX return over 5 years is better than : 40.39 vs. FSTRX (20.00).
FSTRXRMFCXFSTRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD9.85211.42386%
Front LoadN/AN/A-
Min. Initial Investment1500250600%
Min. Initial Investment IRAN/AN/A-
Net Assets1.33B98.7B1%
Annual Yield % from dividends1.081.6964%
Returns for 1 year11.1212.6388%
Returns for 3 years7.5314.1653%
Returns for 5 years20.0040.3950%
Returns for 10 years23.4661.8438%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc